期刊
ACS OMEGA
卷 2, 期 7, 页码 3583-3594出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsomega.7b00527
关键词
-
资金
- National Science Foundation Graduate Research Fellowship Program [1445197]
- American Cancer Society Institutional Research Grant [IRG-58-009-56]
- National Institutes of Health [4R00EB013630]
- NSF [EPS 1004083]
- NIH [CA68485, DK20593, DK58404, DK59637, EY08126]
In this study, we demonstrate the theranostic capability of actively targeted, site-specific multibranched gold nanoantennas (MGNs) in triple-negative breast cancer (TNBC) cells in vitro. By utilizing multiplexed surfaceenhanced Raman scattering (SERS) imaging, enabled by the narrow peak widths of Raman signatures, we simultaneously targeted immune checkpoint receptor programmed death ligand 1 (PDL1) and the epidermal growth factor receptor (EGFR) overexpressed in TNBC cells. A 1: 1 mixture of MGNs functionalized with anti-PDL1 antibodies and Raman tag 5,5dithio- bis-(2-nitrobenzoic acid) (DTNB) and MGNs functionalized with anti-EGFR antibodies and Raman tag paramercaptobenzoic acid (pMBA) were incubated with the cells. SERS imaging revealed a cellular traffic map of MGN localization by surface binding and receptor-mediated endocytosis, enabling targeted diagnosis of both biomarkers. Furthermore, cells incubated with anti-EGFR-pMBA-MGNs and illuminated with an 808 nm laser for 15 min at 4.7 W/cm(2) exhibited photothermal cell death only within the laser spot (indicated by live/dead cell fluorescence assay). Therefore, this study not only provides an optical imaging platform that can track immunomarkers with spatiotemporal control but also demonstrates an externally controlled light-triggered therapeutic approach enabling receptor-specific treatment with biocompatible theranostic nanoprobes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据